Laboratories may choose bacteriostatic water when: Working with multi-dose peptide vials requiring repeated access over days or weeks Conducting extended research protocols where peptides must remain stable in solution Minimizing contamination risk is a priority for experimental validity The peptide application tolerates benzyl alcohol (not for highly sensitive cell culture) Cost-effectiveness through reduced waste is important Laboratories may choose sterile water when: The entire reconstituted peptide solution will be used immediately in a single session Performing cell culture experiments where benzyl alcohol cytotoxicity is a concern Working with sensitive assays where preservatives could interfere with results Maximum purity without any additives is required for the protocol Fresh daily reconstitution aligns with existing laboratory workflows Quality Control Considerations Researchers should source reconstitution solutions exclusively from reputable suppliers with established quality control procedures

Add 2 mL of bacteriostatic water to the 10 mg vial
For a weekly injection schedule where vials remain in use for 4-10 weeks, stability matters significantly
Whats Included (1) 30mL Bacteriostatic Water (USP) Sterile, non-pyrogenic solution Multiple-dose plastic vial Common Uses Laboratory and research applications Clinical preparation environments Sterile compounding processes Product Specifications Volume: 30mL Type: Bacteriostatic Water, USP Preservative: 0.9% Benzyl Alcohol (9 mg/mL) Container: Multi-dose plastic vial with sealed rubber lid Sterility: Sterile and non-pyrogenic Why Buy from AminoVault AminoVault provides high-quality, research-grade supplies with a focus on reliability and convenience
[5] Better health indicators: Subcutaneous fat, while less harmful than visceral fat (fat stored around organs), can still contribute to negative health outcomes when present in excessive amounts
Vidal-Alaball J, Butler CC, Potter CC: Comparing costs of intramuscular and oral vitamin B12 administration in primary care: a cost-minimization analysis